Alibaba Health Information Technology First Half 2024 Earnings: EPS Beats Expectations

Alibaba Health Information Technology (HKG:241) First Half 2024 Results

Key Financial Results

• Revenue: CN¥13.0b (up 13% from 1H 2023).
• Net income: CN¥445.9m (up 178% from 1H 2023).
• Profit margin: 3.4% (up from 1.4% in 1H 2023). The increase in margin was driven by higher revenue.
• EPS: CN¥0.033 (up from CN¥0.012 in 1H 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Alibaba Health Information Technology EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates.

Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Consumer Retailing industry in Hong Kong.

Performance of the Hong Kong Consumer Retailing industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Alibaba Health Information Technology's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.